Etanercept Market Research Report Market Overview The etanercept market focuses on the global demand and supply of this specific biologic drug. Etanercept, marketed under the brand name Enbrel, is a tumor necrosis factor (TNF) blocker used to treat various autoimmune diseases. It works by inhibiting TNF-alpha, a protein involved in inflammation. The market encompasses the production, distribution, and sales of etanercept across different regions and healthcare settings. Key Factors Contributing to Market Growth Rising Prevalence of Autoimmune Diseases: The increasing prevalence of autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, and psoriasis is a major driver of the etanercept market. Growing Elderly Population: The aging population is more susceptible to autoimmune diseases, further increasing the demand for effective treatments like etanercept. Advancements in Medical Research: Ongoing research and development in th...